Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate

References

• Du L, He Y, Zhou Y, Liu S, Zheng BJ, Jiang S. The spike protein of SARS-CoV--a target for vaccine and therapeutic development. Nat Rev Microbiol 2009; 7:226 - 36; http://dx.doi.org/10.1038/nrmicro2090; PMID: 19198616
   PubMed Web of Science ®Google Scholar
• Peiris JSM, Lai ST, Poon LLM, Guan Y, Yam LY, Lim W, Nicholls J, Yee WK, Yan WW, Cheung MT, et al, SARS study group. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003; 361:1319 - 25; http://dx.doi.org/10.1016/S0140-6736(03)13077-2; PMID: 12711465
   PubMed Web of Science ®Google Scholar
• Zhong NS, Zheng BJ, Li YM, Poon, Xie ZH, Chan KH, Li PH, Tan SY, Chang Q, Xie JP, et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People’s Republic of China, in February, 2003. Lancet 2003; 362:1353 - 8; http://dx.doi.org/10.1016/S0140-6736(03)14630-2; PMID: 14585636
   PubMed Web of Science ®Google Scholar
• Jiang S, Bottazzi ME, Du L, Lustigman S, Tseng CT, Curti E, Jones K, Zhan B, Hotez PJ. Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome. Expert Rev Vaccines 2012; 11:1405 - 13; http://dx.doi.org/10.1586/erv.12.126; PMID: 23252385
   PubMed Web of Science ®Google Scholar
• Perlman S, Dandekar AA. Immunopathogenesis of coronavirus infections: implications for SARS. Nat Rev Immunol 2005; 5:917 - 27; http://dx.doi.org/10.1038/nri1732; PMID: 16322745
   PubMed Web of Science ®Google Scholar
• Bolles M, Deming D, Long K, Agnihothram S, Whitmore A, Ferris M, Funkhouser W, Gralinski L, Totura A, Heise M, et al. A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge. J Virol 2011; 85:12201 - 15; http://dx.doi.org/10.1128/JVI.06048-11; PMID: 21937658
   PubMed Web of Science ®Google Scholar
• Castilow EM, Olson MR, Varga SM. Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease. Immunol Res 2007; 39:225 - 39; http://dx.doi.org/10.1007/s12026-007-0071-6; PMID: 17917067
   PubMed Web of Science ®Google Scholar
• Tseng CT, Sbrana E, Iwata-Yoshikawa N, Newman PC, Garron T, Atmar RL, Peters CJ, Couch RB. Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus. PLoS One 2012; 7:e35421; http://dx.doi.org/10.1371/journal.pone.0035421; PMID: 22536382
   PubMed Web of Science ®Google Scholar
• Jaume M, Yip MS, Kam YW, Cheung CY, Kien F, Roberts A, Li PH, Dutry I, Escriou N, Daeron M, et al. SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement. Hong Kong Med J 2012; 18:Suppl 2 31 - 6; PMID: 22311359
   PubMedGoogle Scholar
• Wong SK, Li W, Moore MJ, Choe H, Farzan M. A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. J Biol Chem 2004; 279:3197 - 201; http://dx.doi.org/10.1074/jbc.C300520200; PMID: 14670965
   PubMed Web of Science ®Google Scholar
• Du L, Zhao G, Chan CC, Sun S, Chen M, Liu Z, Guo H, He Y, Zhou Y, Zheng BJ, et al. Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity. Virology 2009; 393:144 - 50; http://dx.doi.org/10.1016/j.virol.2009.07.018; PMID: 19683779
   PubMed Web of Science ®Google Scholar
• Du L, Zhao G, Chan CC, Li L, He Y, Zhou Y, Zheng BJ, Jiang S. A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity. Viral Immunol 2010; 23:211 - 9; http://dx.doi.org/10.1089/vim.2009.0090; PMID: 20374001
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhang L, Qin C, Ba L, Yi CE, Zhang F, Wei Q, He T, Yu W, Yu J, et al. Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region. J Virol 2005; 79:2678 - 88; http://dx.doi.org/10.1128/JVI.79.5.2678-2688.2005; PMID: 15708987
   PubMed Web of Science ®Google Scholar
• He Y, Lu H, Siddiqui P, Zhou Y, Jiang S. Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies. J Immunol 2005; 174:4908 - 15; PMID: 15814718
   PubMed Web of Science ®Google Scholar
• Du L, Zhao G, Li L, He Y, Zhou Y, Zheng BJ, Jiang S. Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells. Biochem Biophys Res Commun 2009; 384:486 - 90; http://dx.doi.org/10.1016/j.bbrc.2009.05.003; PMID: 19422787
   PubMed Web of Science ®Google Scholar
• Goud GN, Zhan B, Ghosh K, Loukas A, Hawdon J, Dobardzic A, Deumic V, Liu S, Dobardzic R, Zook BC, et al. Cloning, yeast expression, isolation, and vaccine testing of recombinant Ancylostoma-secreted protein (ASP)-1 and ASP-2 from Ancylostoma ceylanicum. J Infect Dis 2004; 189:919 - 29; http://dx.doi.org/10.1086/381901; PMID: 14976610
   PubMed Web of Science ®Google Scholar
• Du L, Zhao G, Kou Z, Ma C, Sun S, Poon VK, Lu L, Wang L, Debnath AK, Zheng BJ, et al. Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development. J Virol 2013; 87:9939 - 42; http://dx.doi.org/10.1128/JVI.01048-13; PMID: 23824801
   PubMed Web of Science ®Google Scholar
• Du L, Zhao G, Sun S, Zhang X, Zhou X, Guo Y, Li Y, Zhou Y, Jiang S. A critical HA1 neutralizing domain of H5N1 influenza in an optimal conformation induces strong cross-protection. PLoS One 2013; 8:e53568; http://dx.doi.org/10.1371/journal.pone.0053568; PMID: 23320093
   PubMed Web of Science ®Google Scholar
• Du L, Leung VH, Zhang X, Zhou J, Chen M, He W, Zhang HY, Chan CC, Poon VK, Zhao G, et al. A recombinant vaccine of H5N1 HA1 fused with foldon and human IgG Fc induced complete cross-clade protection against divergent H5N1 viruses. PLoS One 2011; 6:e16555; http://dx.doi.org/10.1371/journal.pone.0016555; PMID: 21304591
   PubMed Web of Science ®Google Scholar
• Du L, Zhao G, Lin Y, Sui H, Chan C, Ma S, He Y, Jiang S, Wu C, Yuen KY, et al. Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection. J Immunol 2008; 180:948 - 56; PMID: 18178835
   PubMed Web of Science ®Google Scholar
• Du L, Zhao G, Lin Y, Chan C, He Y, Jiang S, Wu C, Jin DY, Yuen KY, Zhou Y, et al. Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection. Vaccine 2008; 26:1644 - 51; http://dx.doi.org/10.1016/j.vaccine.2008.01.025; PMID: 18289745
   PubMed Web of Science ®Google Scholar
• He Y, Zhou Y, Liu S, Kou Z, Li W, Farzan M, Jiang S. Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine. Biochem Biophys Res Commun 2004; 324:773 - 81; http://dx.doi.org/10.1016/j.bbrc.2004.09.106; PMID: 15474494
   PubMed Web of Science ®Google Scholar
• He Y, Zhu Q, Liu S, Zhou Y, Yang B, Li J, Jiang S. Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines. Virology 2005; 334:74 - 82; http://dx.doi.org/10.1016/j.virol.2005.01.034; PMID: 15749124
   PubMed Web of Science ®Google Scholar
• He Y, Li J, Li W, Lustigman S, Farzan M, Jiang S. Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein. J Immunol 2006; 176:6085 - 92
   PubMed Web of Science ®Google Scholar
• Punt PJ, van Biezen N, Conesa A, Albers A, Mangnus J, van den Hondel C. Filamentous fungi as cell factories for heterologous protein production. Trends Biotechnol 2002; 20:200 - 6; http://dx.doi.org/10.1016/S0167-7799(02)01933-9; PMID: 11943375
   PubMed Web of Science ®Google Scholar
• Dean N. Asparagine-linked glycosylation in the yeast Golgi. Biochim Biophys Acta 1999; 1426:309 - 22; http://dx.doi.org/10.1016/S0304-4165(98)00132-9; PMID: 9878803
   PubMed Web of Science ®Google Scholar
• Shibata N, Ichikawa T, Tojo M, Takahashi M, Ito N, Okubo Y, Suzuki S. Immunochemical study on the mannans of Candida albicans NIH A-207, NIH B-792, and J-1012 strains prepared by fractional precipitation with cetyltrimethylammonium bromide. Arch Biochem Biophys 1985; 243:338 - 48; http://dx.doi.org/10.1016/0003-9861(85)90511-9; PMID: 3002275
   PubMed Web of Science ®Google Scholar
• Hopkins D, Gomathinayagam S, Rittenhour AM, Du M, Hoyt E, Karaveg K, Mitchell T, Nett JH, Sharkey NJ, Stadheim TA, et al. Elimination of β-mannose glycan structures in Pichia pastoris. Glycobiology 2011; 21:1616 - 26; http://dx.doi.org/10.1093/glycob/cwr108; PMID: 21840970
   PubMed Web of Science ®Google Scholar
• Li F, Li W, Farzan M, Harrison SC. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 2005; 309:1864 - 8; http://dx.doi.org/10.1126/science.1116480; PMID: 16166518
   PubMed Web of Science ®Google Scholar
• Prabakaran P, Gan J, Feng Y, Zhu Z, Choudhry V, Xiao X, Ji X, Dimitrov DS. Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody. J Biol Chem 2006; 281:15829 - 36; http://dx.doi.org/10.1074/jbc.M600697200; PMID: 16597622
   PubMed Web of Science ®Google Scholar
• Zakhartchouk AN, Sharon C, Satkunarajah M, Auperin T, Viswanathan S, Mutwiri G, Petric M, See RH, Brunham RC, Finlay BB, et al. Immunogenicity of a receptor-binding domain of SARS coronavirus spike protein in mice: implications for a subunit vaccine. Vaccine 2007; 25:136 - 43; http://dx.doi.org/10.1016/j.vaccine.2006.06.084; PMID: 16919855
   PubMed Web of Science ®Google Scholar
• Trujillo JD, Kumpula-McWhirter NM, Hötzel KJ, Gonzalez M, Cheevers WP. Glycosylation of immunodominant linear epitopes in the carboxy-terminal region of the caprine arthritis-encephalitis virus surface envelope enhances vaccine-induced type-specific and cross-reactive neutralizing antibody responses. J Virol 2004; 78:9190 - 202; http://dx.doi.org/10.1128/JVI.78.17.9190-9202.2004; PMID: 15308714
   PubMed Web of Science ®Google Scholar